woman in lab coat smiling towards the camera
Visit company website

Nykode is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies.

Nykode is a leader in the rapidly developing field of individualized cancer neoantigen vaccines and is using the Nykode technology to generate best-in-class therapeutics to treat cancers with a high unmet medical need. Nykodes front runner program (VB10.16) is a therapeutic DNA vaccine against HPV16 induced pre-malignancies and malignancies.

Foto: Ingar Næss

Latest news about Nykode

  • Tue Dec 06 2022

    Nykode Therapeutics announces clinical collaboration with MSD

    Nykode Therapeutics Announces Clinical Collaboration with MSD to Evaluate VB10.16 in Combination Wit

    Read full article